These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21789898)

  • 1. Expression of LGR8 and related biomarkers in hepatocellular carcinoma: correlation with clinicopathological parameters.
    Lin CK; Jin JS; Yu CP; Tsai WC
    Chin J Physiol; 2011 Jun; 54(3):161-8. PubMed ID: 21789898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
    Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
    APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)‑2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway.
    Li X; Yang Z; Song W; Zhou L; Li Q; Tao K; Zhou J; Wang X; Zheng Z; You N; Dou K; Li H
    Int J Oncol; 2013 Sep; 43(3):793-802. PubMed ID: 23807724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fascin and cortactin expression is correlated with a poor prognosis in hepatocellular carcinoma.
    Huang X; Ji J; Xue H; Zhang F; Han X; Cai Y; Zhang J; Ji G
    Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):633-9. PubMed ID: 22495401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of vascular endothelial growth factor and matrix metalloproteinase-2 correlates with the invasion and metastasis of hepatocellular carcinoma.
    Liu Z; Yan L; Xiang T; Jiang L; Yang B
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):249-50, 254. PubMed ID: 12856590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cortactin, fascin-1 and epidermal growth factor receptor (EGFR) expression in ovarian carcinomas: correlation with clinicopathological parameters.
    Lin CK; Su HY; Tsai WC; Sheu LF; Jin JS
    Dis Markers; 2008; 25(1):17-26. PubMed ID: 18776588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma.
    Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
    J Cancer Res Clin Oncol; 2006 Sep; 132(9):547-55. PubMed ID: 16763805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of the Notch signaling pathway inhibits hepatocellular carcinoma cell invasion by inactivation of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor.
    Zhou L; Wang DS; Li QJ; Sun W; Zhang Y; Dou KF
    Oncol Rep; 2012 Sep; 28(3):874-82. PubMed ID: 22736202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between high levels of Notch1 expression and high invasion and poor overall survival in hepatocellular carcinoma.
    Zhou L; Zhang N; Li QJ; Sun W; Zhang Y; Wang DS; Dou KF
    Tumour Biol; 2013 Feb; 34(1):543-53. PubMed ID: 23179396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and clinical significance of certain apoptosis and angiogenesis factors in hepatocellular carcinoma].
    Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
    Zhonghua Wai Ke Za Zhi; 2006 Dec; 44(23):1626-30. PubMed ID: 17359695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and clinical impact of vascular endothelial growth factor and matrix metalloproteinase-2 in hepatocellular carcinoma].
    Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):285-8. PubMed ID: 16875630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fascin expression in progression and prognosis of hepatocellular carcinoma.
    Iguchi T; Aishima S; Umeda K; Sanefuji K; Fujita N; Sugimachi K; Gion T; Taketomi A; Maehara Y; Tsuneyoshi M
    J Surg Oncol; 2009 Dec; 100(7):575-9. PubMed ID: 19697358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma.
    Zhao G; Huang ZM; Kong YL; Wen DQ; Li Y; Ren L; Zhang HY
    World J Surg Oncol; 2013 Mar; 11():74. PubMed ID: 23518204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and clinical significance of VEGF and MMP-9 in hepatocellular carcinoma].
    Zhong C; Guo RP; Shi M; Wei W; Yu WS; Li JQ
    Ai Zheng; 2006 May; 25(5):599-603. PubMed ID: 16687082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion.
    Cokakli M; Erdal E; Nart D; Yilmaz F; Sagol O; Kilic M; Karademir S; Atabey N
    BMC Cancer; 2009 Feb; 9():65. PubMed ID: 19239691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
    Zhang J; Zhang DL; Jiao XL; Dong Q
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers.
    Elewa MA; Al-Gayyar MM; Schaalan MF; Abd El Galil KH; Ebrahim MA; El-Shishtawy MM
    Clin Exp Metastasis; 2015 Jun; 32(5):479-93. PubMed ID: 25999065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma.
    Hsu KF; Lin CK; Yu CP; Tzao C; Lee SC; Lee YY; Tsai WC; Jin JS
    Dis Esophagus; 2009; 22(5):402-8. PubMed ID: 19207554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.